Terry M Therneau, PhD

Professor

  • 33042 Citations
  • 91 h-Index
1986 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 5 Similar Profiles
Monoclonal Gammopathy of Undetermined Significance Medicine & Life Sciences
Survival Medicine & Life Sciences
Liver Transplantation Medicine & Life Sciences
Rheumatoid Arthritis Medicine & Life Sciences
Biliary Liver Cirrhosis Medicine & Life Sciences
Multiple Myeloma Medicine & Life Sciences
Population Medicine & Life Sciences
End Stage Liver Disease Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1994 2011

EPIDEMIOLOGIC AND GENETIC STUDIES OF BREAST CANCER

Therneau, T. M., Brandt, K. R., Cerhan, J. R., Olson, J. E., Couch, F. J., Sellers, T. & Thibodeau, S. N.

National Institutes of Health

7/1/006/30/06

Project: Research projectResearch Program Projects

Breast Neoplasms
Mammography
Biostatistics
Epidemiology
Data Management

STUDIES OF MONOCLONAL GAMMOPATHIES

Therneau, T. M., Rajkumar, S. V., Jelinek, D. F., Witzig, T. E., Therneau, T. M., O'Fallon, W., O'Fallon, W. M., O'Fallon, W., Last, J., O'Fallon, W. M., van Ness, B., Kyle, R., Fonsecar, R., Greipp, P., Lust, J. A. & Michael O'Fallon, W.

National Institutes of Health

9/30/941/31/11

Project: Research projectResearch Program Projects

Monoclonal Gammopathy of Undetermined Significance
Multiple Myeloma
Paraproteinemias
Epidemiology
Biostatistics

Research Output 1986 2019

Large Chromosomal Rearrangements Yield Biomarkers to Distinguish Low-Risk From Intermediate- and High-Risk Prostate Cancer

Vasmatzis, G., Kosari, F., Murphy, S. J., Terra, S., Kovtun, I. V., Harris, F. R., Zarei, S., Smadbeck, J. B., Johnson, S. H., Gaitatzes, A. G., Therneau, T. M., Rangel, L. J., Knudson, R. A., Greipp, P. T., Sukov, W. R., Knutson, D. L., Kloft-Nelson, S. M., Karnes, R. J. & Cheville, J. C., Jan 1 2019, In : Mayo Clinic proceedings. 94, 1, p. 27-36 10 p.

Research output: Contribution to journalArticle

Prostatic Neoplasms
Biomarkers
Area Under Curve
Neoplasm Grading
Needle Biopsy

Predicting Progression to Mild Cognitive Impairment

Petersen, R. C., Lundt, E. S., Therneau, T. M., Weigand, S. D., Knopman, D. S., Mielke, M. M., Roberts, R. O., Lowe, V., Machulda, M. M., Kremers, W. K., Geda, Y. E. & Jack, C. R. J., Jan 1 2019, In : Annals of neurology. 85, 1, p. 155-160 6 p.

Research output: Contribution to journalArticle

Biomarkers
Amyloid
Cognitive Dysfunction
Alzheimer Disease
Population

Application of multi-state models in cancer clinical trials

Le-Rademacher, J., Peterson, R. A., Therneau, T. M., Sanford, B. L., Stone, R. M. & Mandrekar, S. J., Jan 1 2018, (Accepted/In press) In : Clinical Trials.

Research output: Contribution to journalArticle

4'-N-benzoylstaurosporine
Clinical Trials
Proportional Hazards Models
Neoplasms
Software

Considerations for performing level-2 centiloid transformations for amyloid PET SUVR values

Schwarz, C. G., Tosakulwong, N., Senjem, M. L., Gunter, J. L., Therneau, T. M., Vemuri, P. D., Lowe, V. & Jack, C. R. J., Dec 1 2018, In : Scientific Reports. 8, 1, 7421.

Research output: Contribution to journalArticle

Linear regression
Amyloid
Manuscripts
Pharmacokinetics
Genes
Neoplasms